Clovis Oncology DPO Ratio 2011-2026 | CLVS

Annual DPO Ratio Clovis Oncology

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	236	339	472	471	56.9 K	-	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
56.9 K	236	11.7 K

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	260	-	-	-	296	-	-	-	-	-	546	580	497	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
580	260	436

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Alnylam Pharmaceuticals ALNY	55	$ 320.13	-3.98 %	$ 41.9 B	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Amphastar Pharmaceuticals AMPH	31.7	$ 21.81	0.6 %	$ 1.02 B	USA
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
Akebia Therapeutics AKBA	168	$ 1.35	-12.9 %	$ 347 M	USA
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
Aquestive Therapeutics AQST	395	$ 4.26	0.47 %	$ 456 M	USA
AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain
Arcutis Biotherapeutics ARQT	133	$ 24.19	-1.59 %	$ 3.08 B	USA
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	96.3	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	9.57	$ 1.61	8.05 %	$ 428 M	Britain
BeiGene, Ltd. BGNE	915	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	182	-	-	$ 546 M	USA
BioXcel Therapeutics BTAI	34.2 K	$ 1.07	1.9 %	$ 13.1 M	USA
ChromaDex Corporation CDXC	76.3	-	-0.88 %	$ 598 M	USA